[HTML][HTML] Implications of insulin-like growth factor-1 in skeletal muscle and various diseases

SS Ahmad, K Ahmad, EJ Lee, YH Lee, I Choi - Cells, 2020 - mdpi.com
Skeletal muscle is an essential tissue that attaches to bones and facilitates body
movements. Insulin-like growth factor-1 (IGF-1) is a hormone found in blood that plays an …

[HTML][HTML] The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy

K Kiełbowski, E Bakinowska, G Procyk… - International Journal of …, 2024 - mdpi.com
Duchenne muscular dystrophy (DMD) is an X-linked progressive disorder associated with
muscle wasting and degeneration. The disease is caused by mutations in the gene that …

[HTML][HTML] Cardiac MRI and echocardiography for early diagnosis of cardiomyopathy among boys with Duchenne muscular dystrophy: a cross-sectional study

N Prakash, R Suthar, BK Sihag, U Debi… - Frontiers in …, 2022 - frontiersin.org
Background Cardiomyopathy is an important cause of morbidity and mortality in boys with
Duchenne muscular dystrophy (DMD). Early diagnosis is a prerequisite for timely institution …

[HTML][HTML] Duchenne muscular dystrophy: still an incurable disease

H Arora - Neurology India, 2019 - journals.lww.com
Muscular dystrophies (MDs) are heterogeneous, genetic muscle disorders.[1-6] Genetic
mapping techniques have helped to identify more than 50 diseases, caused by specific …

[HTML][HTML] Ambulatory Duchenne muscular dystrophy children: Cross-sectional correlation between function, quantitative muscle ultrasound and MRI

H Abdulhady, HM Sakr, NS Elsayed, TA El-Sobky… - Acta …, 2022 - ncbi.nlm.nih.gov
Duchenne muscular dystrophy (DMD) is a progressive genetic muscle disease. Quantitative
muscle ultrasound (US), muscle MRI, and functional tools are important to delineate …

[HTML][HTML] Dystrophin gene editing by CRISPR/Cas9 system in human skeletal muscle cell line (HSkMC)

M Dara, V Razban, M Mazloomrezaei… - Iranian Journal of …, 2021 - ncbi.nlm.nih.gov
Objective (s): Duchene muscular dystrophy (DMD) is a progressive neuromuscular disease
caused by mutations in the DMD gene, resulting in the absence of dystrophin expression …

Feasibility and effectiveness of a soft exoskeleton for pediatric rehabilitation

MA Lobo, B Li - … Robotics: Challenges and Trends: Proceedings of the …, 2022 - Springer
Exoskeletons have the potential to improve outcomes for rehabilitation clients. For these
devices to be effective, rehabilitation professionals and end users must be involved …

Identification of plasma interleukins as biomarkers for deflazacort and omega-3 based Duchenne muscular dystrophy therapy

SC de Carvalho, CY Matsumura, H Santo Neto… - Cytokine, 2018 - Elsevier
Duchenne muscular dystrophy (DMD) is a progressive and fatal disease, characterized by
the absence of dystrophin, muscle degeneration and cardiorespiratory failure. Creatine …

DMD‐related muscular dystrophy in Cameroon: Clinical and genetic profiles

E Wonkam‐Tingang, S Nguefack… - Molecular genetics & …, 2020 - Wiley Online Library
Background Most of the previous studies on Duchenne Muscular Dystrophy (DMD) were
conducted in Caucasian, Asian, and Arab populations. Therefore, little is known about the …

[HTML][HTML] Development and Economic Evaluation of a Patient-Centered Care Model for Children With Duchenne Muscular Dystrophy: Protocol for a Quasi-Experimental …

T Sirari, R Suthar, A Singh, S Prinja… - JMIR Research …, 2023 - researchprotocols.org
Background: Duchenne muscular dystrophy (DMD) is a rare progressive muscular disease
that primarily affects boys. A lack of comprehensive care for patients living with DMD is …